Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Biopharma Co. Makes Major Headway Toward Clinical Trials for Treatment of Stroke

(CLICK IMAGE TO PLAY VIDEO) Finding an effective method of preventing the possibility of stroke is something that medical science has grappled with for decades. Now, a Vancouver-based clinical stage biopharmaceutical development company looks to be making significa...

The Company That’s Delivering Safe, Evidence-Based Psychedelic-Assisted Psychotherapies

(Click image to play podcast) Stockhouse investors who are dialed into the not-only nascent but now, pardon the pun, mushrooming psychedelics sector are likely familiar with a mental health and wellness company “centred on developing and supporting the safe, ev...

Gold In Pre-Recession World

The yield curve has inverted. It suggests that we are about one year before the recession. How should the yellow metal behave in such a period? We invite you to read our today’s article and find out how gold is likely to behave in the pre-recession world. ...

Vir Biotech Shares Rise on Joint Research Efforts with the NIH to Combat Coronaviruses

Vir Biotechnology shares traded higher after the company reported that it has entered into a research collaboration with the National Institutes of Health Vaccine Research Center on antibodies against coronaviruses including SARS-CoV-2. Clinical-stage immuno...

Favourable Ruling for Emerita Resources on the Aznalcollar Zinc-Lead-Silver Project in Spain

Full size / The Aznalcóllar open-pit near Seville in southern Spain ( source ). Good news for Emerita Resources Corp. as the company today announced favourable ruling on the Aznalcóllar Zinc-Lead-Silver Project appeal. This is making headlines in the news at...

PART II - Black Hole In Global Banking Is Being Exposed

Nearly a decade ago, the globe experienced the biggest banking system failures we had seen in nearly a century. The exposure to risk that was inherent throughout the global banking system was so completely ignored that when the crisis unfolded, hardly anyone completely underst...

Three More Years of Expansion? How Will Gold React?

We are just a few weeks from breaking the record. If the current US economic expansion lasts until July 2019, it will reach 121 months, becoming the longest ever. The extended duration of the prosperity begs the question of when the next downturn will occur. We invite you to r...

US Stock Market Sets Up Technical Patterns – Pay Attention

The recent “melt-up” in the US stock market after a moderate downside price move in early May 2020 has set up a number of technical patterns that traders need to pay attention to. This melt-up trend may continue for a bit longer, but price levels and ac...

Will Gold Benefit from Trump Impeachment Proceedings?

This week, Nancy Pelosi announced that the House would launch a formal impeachment inquiry. Is it a well-grounded argument, publicity stunt or reflection of the growing polarization inside the Democratic party? Storm in a tea cup or not, should Trump be worried? And gold? W...

Iovance Biotherapeutics Shares Rise 12% on Updated Phase 2 Melanoma Study Results

Shares of Iovance Biotherapeutics traded 12% higher today after the firm reported updated clinical data from its phase 2 lifileucel metastatic melanoma trial. Just a few days after reporting third quarter 2019 earnings, late-stage biotechnology company Iovance Biothe...
1 2 3 4 5 6 7 8 9 10 ...